Table 3. Subgroup analyses for dominant model, recessive model and the allele contrast I versus D.
Intervention group (n) | Dominant model | Recessive model | The allele contrast I versus D | |||||||
I2 | RE pooled ORs (95% CI) | P | I2 | RE pooled ORs(95% CI) | P | I2 | RE pooled OR (95% CI) | P | ||
Mean age | ||||||||||
≤60 y, low median | 5 | 0% | 0.87 (0.64, 1.18) | <0.05 | 1% | 1.12 (0.88, 1.42) | <0.05 | 0% | 1.01 (0.85, 1.20) | 0.0001 |
>60 y, high median | 4 | 0% | 2.71 (1.60, 4.61) | 0% | 2.39 (1.67, 3.43) | 0% | 2.07 (1.61, 2.68) | |||
Category of ACEIs | ||||||||||
enalapril (or major) | 4 | 42% | 1.04 (0.52, 2.09) | 0.4307 | 44% | 1.52 (0.77, 3.01) | 0.6334 | 70% | 1.30 (0.73, 2.35) | 0.7469 |
others | 7 | 63% | 1.23 (0.73, 2.09) | 58% | 1.65 (1.14, 2.40) | 67% | 1.36 (1.02, 1.81) | |||
Interval of treatment | ||||||||||
>2 months | 4 | 0% | 0.96 (0.67, 1.37) | 0.1155 | 7% | 1.09 (0.81, 1.47) | 0.0016 | 0% | 0.95 (0.79, 1.14) | 0.0023 |
≤2months | 5 | 67% | 1.56 (0.75, 3.24) | 0% | 2.03 (1.47, 2.80) | 50% | 1.57 (1.15, 2.13) | |||
Proportion of male | ||||||||||
<60%, low median | 4 | 72% | 1.59 (0.67, 3.80) | 0.2530 | 0% | 1.85 (1.29, 2.66) | 0.2895 | 78% | 1.39 (0.90, 2.17) | 1.0000 |
>60%, high median | 3 | 67% | 0.87 (0.28, 2.69) | 67% | 1.46 (0.75, 2.83) | 40% | 1.39 (0.91, 2.13) | |||
Population | ||||||||||
Asian | 7 | 65% | 1.49 (0.78, 1.74) | 0.0012 | 65% | 1.82 (1.20, 2.74) | 0.0298 | 73% | 1.55 (1.11, 2.16) | 0.0042 |
Caucasian | 4 | 0% | 0.85 (0.58, 1.25) | 0% | 1.23 (0.77, 1.98) | 5% | 0.99 (0.76, 1.31) |